Home International News FDA Authorizes Novavax’s Updated COVID-19 Vaccine Targeting the XBB.1.5 Strain
International NewsLatest News

FDA Authorizes Novavax’s Updated COVID-19 Vaccine Targeting the XBB.1.5 Strain

Share
Novavax Vaccine Expanded to Target XBB.1.5 Variant
Novavax Vaccine Expanded to Target XBB.1.5 Variant
Share

New Delhi, September 2: The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Novavax’s updated COVID-19 vaccine. Specifically targeting the XBB.1.5 variant, which was the dominant strain circulating in the United States earlier this year. The authorization comes as health officials continue to monitor the evolving COVID-19 landscape and the emergence of new variants.

Novavax’s updated jab designed to provide protection against the XBB.1.5 variant, which is a descendant of the Omicron variant. This variant was particularly concerning due to its increased transmissibility and its ability to evade immune responses induced by previous COVID-19 vaccines.

FDA Authorizes Updated Novavax COVID-19 Vaccine

The FDA’s decision to authorize Novavax’s updated vaccine is based on data from clinical trials that demonstrated its safety and efficacy against the XBB.1.5 variant.

The vaccine found to be well-tolerate, with mild to moderate side effects such as injection site pain, fatigue, and muscle aches.

The authorization of Novavax’s updated vaccine provides individuals with an additional option for COVID-19 vaccination. It is particularly significant for those who may have concerns about mRNA jabs. As Novavax’s jab uses a different technology known as protein subunit technology. This technology involves using a protein from the virus to stimulate an immune response.

While the XBB.1.5 variant is no longer the dominant strain in the United States. it remains a concern, and the FDA’s authorization of Novavax’s updated jab is a proactive step to ensure that individuals have access to the most effective protection against emerging COVID-19 variants.

It’s important to note that the Centers for Disease Control and Prevention (CDC) recommends that individuals stay up-to-date on COVID-19 vaccinations. Which includes receiving booster shots as recommended. The CDC also emphasizes the importance of other preventive measures. Such as wearing masks in crowded indoor settings, maintaining social distancing, and practicing good hand hygiene.

As the COVID-19 pandemic continues to evolve, it’s essential to stay informed about the latest recommendations and guidance from health officials. By getting vaccinate and following preventive measures. Individuals can help protect themselves and their communities from the virus.

Additional Information On New COVID Vaccine

  1. The FDA’s authorization for Novavax’s update vaccine based on data from clinical trials conducted in adults aged 18 and older.
  2. The vaccine administered as a two-dose series, with the second dose given three weeks after the first.
  3. Individuals who have already received a primary series of COVID-19 vaccination and a booster shot may be eligible for an additional booster dose of the updated vaccine.
  4. The FDA’s decision to authorize Novavax’s updated vaccine is a significant step in the ongoing fight against COVID-19.

Read Also – Understanding the Connection Between Sleep and Heart Attack Prevention

The availability of Novavax’s updated COVID-19 jab provides individuals with an additional option for protection against the virus. The jab’s authorization by the FDA is a significant step in the ongoing fight against COVID-19, particularly as new variants continue to emerge. By staying informed about the latest recommendations and taking appropriate preventive measures, individuals can help protect themselves and their communities from the virus.

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Bundibugyo Ebola virus
International NewsVirus & DiseaseWHO

From Fever To Organ Failure: How The Bundibugyo Ebola Virus Affects The Body

The Bundibugyo Ebola virus outbreak has raised fresh global health concerns as infections continue to spread across parts of Central and East Africa....

WHO
Health TipsInternational NewsLatest NewsLifestyle & WellnessWHO

WHO Issues First Type 1 Diabetes Guidelines for Adults: 7 Things Patients Need to Know

More than 100 years after the discovery of insulin, millions of people living with type 1 diabetes continue to face challenges in accessing...

Breast Cancer
Health NewsOncology

Mammogram vs Ultrasound vs MRI: Which Breast Cancer Screening Test Is Right for You?

Breast cancer is one of the most common cancers affecting women worldwide, and early detection plays an important role in improving treatment outcomes....

Always Tired? It Could Be Anaemia!
Diet & NutritionHealth NewsHealth TipsLifestyleLifestyle & WellnessWellness

Anaemia in India: Why Iron Deficiency Remains a Concern and 7 Signs You Should Not Ignore

Feeling tired all the time, experiencing frequent dizziness or getting breathless after climbing a few stairs? While these symptoms are often dismissed as...

N95 Mask
Health TipsLatest NewsLifestyle & WellnessWellness

Does Wearing an N95 Mask Protect You From PM2.5 Pollution? Doctors Explain How To Choose And Wear It Correctly

As air pollution continues to affect several Indian cities during winter, wearing a mask has become an important precaution for people stepping outdoors....

Section title

Related Articles
Latest NewsWHO

WHO Releases First-Ever Guidelines For Type 1 Diabetes In Adults: 5 Key Recommendations Explained

The World Health Organization (WHO) has issued its first-ever guidelines for the...

Health NewsLatest NewsLifestyle

7 Simple Ways to Protect Yourself from Air Pollution

Air pollution has become a major health concern today. Dust from construction...